Fabricating covalent organic framework capsules with commodious microenvironment for enzymes by Li, Mingmin et al.
Subscriber access provided by Library, Univ of Limerick | Supported by IReL
is published by the American Chemical Society. 1155 Sixteenth Street N.W.,
Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.
Article
Fabricate Covalent Organic Framework Capsules
with Commodious Microenvironment for Enzymes
Mingmin Li, Shan Qiao, Yunlong Zheng, Yassin H Andaloussi, Xia Li,
Zhenjie Zhang, Ang Li, Peng Cheng, Shengqian Ma, and Yao Chen
J. Am. Chem. Soc., Just Accepted Manuscript • DOI: 10.1021/jacs.0c00285 • Publication Date (Web): 20 Mar 2020
Downloaded from pubs.acs.org on March 24, 2020
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.
1
Fabricate Covalent Organic Framework Capsules with Commodious 
Microenvironment for Enzymes
Mingmin Li,† Shan Qiao,† Yunlong Zheng,† Yassin H. Andaloussi,‡ Xia Li,‡  Zhenjie Zhang,‡,§ Ang Li,† 
Peng, Cheng,§ Shengqian Ma⊥ and Yao Chen*,†
† State Key Laboratory of Medicinal Chemical biology, College of Pharmacy, Nankai University, Tianjin 300071, China 
§ College of Chemistry, Nankai University, Tianjin, 300071, China
‡ Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick V94 T9PX, Republic of Ireland
⊥ Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, Florida 33620, United States
KEYWORDS: covalent organic frameworks, capsule, immobilization, biomacromolecules, biocatalysis
ABSTRACT: Enzyme immobilization has demonstrated itself to be a favorable protocol to promote industrialization of 
biomacromolecules. Despite tremendous efforts to develop new strategies and materials to realize this process, maintaining 
enzyme activity is still of formidable challenge. Herein, we created a sacrificial templating method, using metal-organic 
frameworks (MOFs) as sacrificial templates to construct hollow covalent organic framework (COF) capsules for enzyme 
encapsulation. This strategy can provide capacious microenvironment to unleash enzyme molecules. The improved 
conformational freedom of enzymes, enhanced mass transfer and protective effect against external environment ultimately 
boosted the enzymatic activities. We also found that this strategy possesses high versatility that is suitable for diverse 
biomacromolecules, MOF templates and COF capsules. Moreover, the dimensions, pore sizes and shell thickness of COF 
capsules can be conveniently tuned, allowing for customizing bioreactors for specific functions. For example, co-
encapsulation of different enzymes with synergistic functions were successfully demonstrated using this bioreactor platform. 
This study not only opens up a new avenue to overcome the present limitations of enzymatic immobilization in porous 
matrixes, but also provides new opportunities for construction of bio-microdevices or artificial organelles based on crystalline 
porous materials.
INTRODUCTION
As natural catalysts, enzymes possess fascinating 
characteristics, such as high efficiency, regio- and 
stereoselectivity, allowing for continual advances in 
biotechnological applications.1,2 However, the intrinsically 
fragile nature of enzymes greatly impedes their 
industrialization. Enzyme immobilization has become a 
favorable strategy with increased stability and reusability, 
easy operation, energy conservation and continuous-flow 
production, prompting the application of enzymes.3-11 
Despite these merits, most confined enzymatic systems still 
confront great challenges. For instance, tightly packed 
enzymes within host materials typically lack 
conformational freedom that may greatly affects molecular 
recognition.12,13 Mass transfer of substrates or products can 
also be a limiting factor, and thus internally-adsorbed 
enzymes may display substantially reduced activity.14,15 
Moreover, traditional incorporation methods such as 
adsorption often suffer from low loading or high leaching 
due to weak interaction or pore size mismatching.16 
Exploration of new platforms to overcome these challenges 
for optimal enzyme performance in confined space is, 
therefore, in urgent demand.
Compartmentalization of biomacromolecules is a 
common phenomenon in living systems.17,18 The eukaryotic 
cell is a prototypical example whereby the unique 
biochemical microenvironment allows the spatial control of 
various functions. Such enclosed units confer physical 
protection against external disturbance, while maintaining 
a certain degree of freedom for the internal contents.19,20 
Inspired by nature, the design and construction of 
biomimetic ‘smart capsules’ can be a promising approach to 
overcome the challenges of confined enzymatic systems.21-
23 Organic polymer and inorganic nanoparticles are 
materials commonly used to prepare capsules through 
various approaches.18,24,25 However, they may suffer from 
irregular structure or lack of chemical functionality.26,27 
Covalent organic frameworks (COFs) are an emerging class 
of crystalline porous materials with high and well-defined 
porosity, high stability, and readily engineered 
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functionality, allowing them as excellent hosts for enzyme 
encapsulation.28-31 However, the harsh synthetic conditions 
required in the fabrication of COFs make it impractical to 
directly make COF capsules encapsulating 
biomacromolecules through a “one-pot” strategy.32-34 The 
sister material of COFs, metal-organic frameworks (MOFs) 
can in-situ encapsulate biomacromolecules to form 
biomacromolecule@MOF (@ = encapsulating) with high 
loading and good protection.35-38 However, this often results 
in a penalty to lose the conformational freedom of enzymes, 
leading to a detrimental effect on enzyme activity. Many 
reports including our recently work have proved that 
biomacromolecule@MOF can be easily digested to release 
biomacromolecules without losing their bioactivities which 
render MOFs as perfect sacrificial templates to make COF 
capsules.37 Combining the benefits of both COFs and MOFs 
to form ‘smart capsules’ may open up new opportunities to 
greatly enhance the performance of confined enzyme: i) the 
MOF encapsulation can protect enzymes from harsh 
synthetic conditions, such as those amenable to COF 
formation, allowing for COFs to directly coat on 
enzyme@MOF particles; ii) the high porosity of COF shells 
then allows for subsequent digestion of MOF cores while 
facilitating mass transfer of substrates resulting in active, 
conformationally unhindered enzymes within a protective 
COF capsule. 
Herein, we created a versatile approach to fabricate 
biomimetic ‘smart COF capsules’ for the encapsulation of 
active biomacromolecules. Biomacromolecules are first 
encapsulated within digestible MOFs via in-situ 
encapsulation to form biomacromolecules@MOF which can 
protect biomacromolecules and act as templates for the 
growth of biomarcomolecule@MOF@COF core-shell 
structures. Finally, the MOF core was etched away to 
liberate the biomacromolecules within the hollow COF 
capsule (Scheme 1). Such a commodious microenvironment 
in the formed biomacromolecule@COF offers protective 
effects while maintaining the conformational freedom of 
biomacromolecules and facilitating the mass transfer of 
substrates/products, which is essential for high activity or 
synergistic effect of different enzymes. This study opens up 
a new avenue to overcome the present limitations of 
enzymatic immobilization in porous matrixes.
Scheme 1. Schematic illustration of the stepwise approach to 
construct biomacromolecule@capsule.
RESULTS AND DISCUSSION
Materials Preparation and Characterizations. A 
supporting matrix is required for COF capsule formation in 
order to protect enzymes against harsh synthetic conditions 
and to act as a template. ZIF-90 has been previously shown 
to efficiently load various biological active macromolecules 
(e.g. enzymes) and protect them against harsh conditions 
while also being feasibly digested under mildly acidic 
conditions.35-37 Thus, ZIF-90 is a perfect candidate to 
demonstrate the concept due to the presence of unreacted 
aldehyde groups in the ligand 2-imidazolecarbaldehyde 
(ICA), which could be anticipated in the amine-aldehyde 
condensation reaction involved in a subsequent COF 
formation, and therefore allows the MOF particles as 
templates in the formation of COF shells (Figure 1). In order 
to maintain the activity of biomacromolecules during the 
synthesis process, an acid-stable COF that can be 
synthesized under mild conditions is then required for the 
construction of capsules, for which COF-42 was chosen.39,40 
COF-42 was synthesized via the room temperature 
condensation of 1,3,5-triformylbenzene (TB) and 2,5-
Bis(ethoxy)terephthalohydrazide (BETH) under acetic acid 
catalysis. However, because protic acids could decompose 
the enzyme@MOF complexes, a MOF-compatible catalyst, 
Sc(OTf)3,41 was used instead of acetic acid. Various 
structural analogues of the BETH monomer were screened 
to find one that produced a crystalline COF-42 product 
(Table S1, Figure S1 and S2). It was found that only 2, 5-
Bis(butenyloxy)terephthalohydrazide (BBTH) succeeded to 
afford a crystalline COF-42 analogue (named as COF-42-B) 
which was stable under acid condition (e.g. pH = 5, 
phosphate buffer (PB) solution, 50 mM) (Figure S3 and S4).
Figure 1. Illustration of the synthetic route of 
biomacromolecule@COF capsules. (a) Immobilizing 
biomacromolecules in ZIF-90 via an in-situ encapsulation 
method; (b) A one-pot reaction of ZIF-90 with COF monomers; 
(c) Illustration of the core-shell structure of 
biomacromolecule@ZIF-90@COF-42-B (middle), structure of 
COF-42-B (left), a TEM image of the core-shell structure (right); 
(d) Illustration of the capsule structure of 
biomacromolecule@COF-42-B (middle), EDS carbon 
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distribution (left) and a TEM image (right) of 
biomacromolecule@COF-42-B capsule.
Figure 2. Characterizations of BSA@COF-42-B capsule. (a) 
PXRD patterns of products in different synthesis stage. 
BSA@ZIF-90 (blue), BSA@ZIF-90@COF-42-B (purple), 
BSA@COF-42-B (green), calculated pattern of ZIF-90 (black) 
and COF-42-B (red); (b) TEM images showing BSA@ZIF-
90@COF-42-B precursors (upper) and BSA@COF-42-B 
capsules (below) with different shell thickness tuned via 
adding different amounts of BSA@ZIF-90 (from left to right, 6.0 
mg, 9.0 mg, 12.0 mg, 15.0 mg and 18.0 mg). Scale bar: 100 nm. 
In order to verify the construction strategy of COF 
capsules, BSA (Bovine Serum Albumin) was chose as a 
model biomacromolecule on the basis of its low cost and 
high solubility. BSA@ZIF-90 was first prepared via the in-
situ encapsulation method according to literature.36 The 
encapsulation efficiency of BSA was measured to be as high 
as 99%, using a standard Bradford Assay, and the loading 
percentage was calculated to be 0.22 g BSA per g ZIF-90 
(Figure S5). Subsequently, the as-prepared BSA@ZIF-90 
was mixed with TB, BBTH and Sc(OTf)3 in 1, 4-
dioxane/mesitylene (3:1 v/v) for 30 min. PXRD patterns, 
TEM images, showed a combination of two crystalline 
phases (i.e. ZIF-90 and COF-42-B) (Figure 2 and S6), 
indicating the existence of BSA@ZIF-90@COF-42-B. FT-IR 
results further verified the successful encapsulation of BSA 
(Figure S7). Our previous result has demonstrated that ZIF-
90 can be digested in aqueous solution with pH < 7.37 We 
then exposed the as-prepared BSA@ZIF-90@COF-42-B to a 
PB solution (pH = 5, 50 mM). The progress of digesting 
reaction was monitored by TEM, which showed a clear 
transformation from the core-shell structure to a hollow 
capsule within 1 h. Tracking characteristic PXRD peaks of 
ZIF-90 afforded a result consistent with TEM data (Figure 
S8 and S9). Energy dispersive spectrometer (EDS) element 
mapping further demonstrated the successful construction 
of COF-42-B capsules (Figure 1d). Porosity of these 
materials was found to be retained during the synthetic 
procedure (Figure S10). N2 sorption data collected at 77 K 
revealed the Langmuir surface areas of 1390 m2/g, 610 
m2/g, 436 m2/g and 835 m2/g, BET surface areas of 723 
m2/g, 367 m2/g, 235 m2/g and 530 m2/g, pore size 
distribution centered around 0.9 nm, 1.8 nm, 1.2 nm, and 
1.8 nm for BSA@ZIF-90, COF-42-B, BSA@ZIF-90@COF-42-
B and BSA@COF-42-B, respectively. Moreover, it was found 
that the thickness of the COF-42-B shell could be readily 
adjusted by altering the amount of added BSA@ZIF-90. 
Upon increasing the amount of BSA@ZIF-90, the PXRD 
reflection peaks assigned to ZIF-90 exhibited increased 
intensity relative to the intensity of the COF-42-B peaks 
(Figure S11), and TEM images showed the COF shell varying 
from 130 nm to 15 nm (Figure 2b). A control experiment 
was further performed to test if BSA can be directly 
incorporated into COF-42-B via the traditional pore 
adsorption method. The attempt failed because the channel 
size of COF-42-B was much smaller than the molecule size 
of BSA (Figure S12).
Exploration of the generality of capsule fabrication 
strategy. In order to explore the generality of this synthetic 
strategy, we examined the use of ZPF-2 (ZPF = Zeolitic 
Pyrimidine Framework) as the sacrificial template, instead 
of ZIF-90. ZPF-2 with a sod topology was synthesized from 
Zn(NO3)2·6H2O and 2-Hydroxy-5-fluoropyrimidine (Figure 
S13) in aqueous solution at room temperature.42 Herein, for 
the first time, we demonstrated that ZPF-2 can efficiently 
incorporate biomacromolecules via in-situ encapsulation 
method. As revealed by TEM, PXRD, and FT-IR (Figure S14-
S16), ZPF-2 can efficiently encapsulate BSA and serve as a 
sacrificial template to yield hollow BSA@COF-42-B 
capsules. Additionally, we found that digesting rate of ZPF-
2 was faster than ZIF-90 and the MOF cores was completely 
removed in 10 min (Figure S17). Moreover, we found ZIF-8 
can also be applied to fabricate COF capsules via a similar 
approach as ZIF-90 and ZPF-2 (Figure S18-S20). However, 
only a relatively small amount of ZIF-8 could be 
incorporated within COF-42-B because increased amounts 
of ZIF-8 inhibited the formation of COF-42-B. We also 
explore whether other COF materials can be used to make 
COF capsules. A hollow COF capsule containing BSA was 
successfully fabricated by COF-43-B (Figure S21 and S22).39 
This stepwise strategy has, therefore, proven to be an 
adaptable method to fabricate biomacromolecules-
containing hollow COF capsules that could foreseeably be 
modified for use in highly specific applications.
Biocatalysis application of COF capsules. On the basis 
of the successful encapsulation of BSA in COF capsules, we 
further explored whether enzymes can be trapped within 
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COF capsules. CAT is a well-known multimeric protein with 
four subunits, which can catalyze the breakdown of 
hydrogen peroxide (H2O2) to generate O2 and H2O, 
protecting cells from the oxidative damage caused by 
hydrogen peroxide.43 In order to immobilize CAT within 
COF capsules, ZPF-2 was selected as the model sacrificial 
MOF. EDS mapping was performed to confirm the successful 
encapsulation of CAT within the capsules. As shown in 
Figure 3, Fe, the characteristic element present in CAT, was 
uniformly dispersed in all samples; indicative of the 
successful encapsulation of CAT. Additionally, confocal 
images further verified the uniform dispersion of CAT in all 
samples (Figure S23), and circular dichroism (CD) and UV-
Vis spectra confirmed that the structure of CAT was 
retained during this synthesis process (Figure S24).
Figure 3. Bright field images (left) and EDS elemental mapping 
(right) of Fe, Zn and C for (a) CAT@ZPF-2, (b) CAT@ZPF-
2@COF-42-B and (c) CAT@COF-42-B.
Factors such as particle size and capsule shell thickness 
were also investigated to optimize the catalytic activity of 
this novel enzyme-incorporated system. A series of CAT-
loaded ZPF-2 crystals with particle sizes ranging from 100 
nm to 8000 nm were synthesized (Figure S25). TEM images 
were used to confirm particle size uniformity for each 
sample (Figure S26a). Catalytic activity towards H2O2 was 
evaluated via the FOX method (Figure S27 and S28). With 
the same amount of enzymes, CAT@ZPF-2 achieved the 
highest Kobs of 0.0473 s-1 with a particle size of ~1500 nm. 
COF capsule shell thickness was also tuned by varying the 
amount of added CAT@ZPF-2 core (with particle size of 
~1500 nm). The results reveal that the activity of 
enzyme@COF-42-B capsules obeyed a Gaussian 
distribution when shell thickness was modified (Figure 
S29), and the best performance was achieved with a shell 
thickness of ~60 nm (Kobs = 0.0743 s-1) (the loading 
capabilities was 1.66 g/g). Generally, the thicker capsule 
shell is, the higher mass transfer resistance exists. Besides 
thickness, capsule size of COF-42-B also plays a crucial role 
in the activity of encapsulated enzymes. Thereafter, we 
prepared a series of COF capsules in the range of 350-1500 
nm, with a capsule thickness of ~60 nm (Figure S26b-g), 
and found that capsules of ~1500 nm exhibited the best 
performance (Figure S30). Thus, the optimized COF 
capsules of ~1500 nm size and ~60 nm thickness were used 
for further study. 
The biocatalytic assay revealed that CAT@ZPF-2@COF-
42-B before MOF etching presented 49% lower enzyme 
activity than CAT@ZPF-2, which should be ascribed to the 
high mass transfer resistance in CAT@ZPF-2@COF-42-B. 
After etching treatment, the generated CAT@COF-42-B 
capsule demonstrated a dramatic 58% improvement of 
activity compared to CAT@ZPF-2, which could be 210% 
when compared to CAT@ZPF-2@COF-42-B (Figure 4a). 
Negligible leaching of CAT was detected during the etching 
process (Figure S31). A further comparison of the kinetics 
of CAT@ZPF-2 and CAT@COF-42-B revealed that their Vmax 
and KM were 2.73 M/s and 0.0625 mM, and 3.98 M/s and 
0.0531 mM, respectively (Figure S32). Although their 
activities are lower than free CAT (Figure S33), the results 
show significantly boosted biocatalytic activity for 
CAT@COF-42-B capsule structure after the removal of 
MOFs, indicating the unleashing CAT molecules from the 
tightly packed MOF composite to the commodious 
microenvironment of COF capsules is beneficial for 
enzymatic performance. Additionally, we also investigate 
the CAT-loaded COF-43-B capsules which showed a similar 
trend as COF-42-B (Figure S34). After optimization, the 
activity of CAT@COF-43-B exceeded CAT@COF-42-B and 
showed an increase up to 81% compared with that of 
CAT@ZPF-2 (Figure 4b) (loading capabilities was 1.49 g/g). 
This result is probably due to the larger pore size of COF-
43-B (3.2 nm) compared with COF-42-B (1.9 nm) (Figure 
S35) that facilitate the mass transport of substrates and 
products. These results indicate that the synthetic strategy 
can be applied as a versatile and tunable approach for on-
demand preparation of high efficient bioreactor based on 
COF capsules.
Exploration of protection effect and reusability of 
COF capsules. The protection effect of the formed COF 
capsules was examined under various perturbation 
conditions, such as acid, proteases, acetone and high 
temperature (Figure 4c). CAT@COF-42-B prepared via 
CAT@ZPF-2 was selected as a representative. First, we 
assessed its acid tolerance in disodium hydrogen 
phosphate-citric acid buffer (100 mM, pH = 4) for 30 min. 
CAT@COF-42-B was seen to retain 85% of its original 
activity while free CAT retained only 35%, and CAT@ZPF-2 
lost almost all activity (>99%) due to the leaching of CAT 
resulted from dissolution of ZPF-2 under the acidic 
condition (Figure S36a). COF-42-B was shown to protect 
CAT with 95% of original activity retained after exposure to 
acetone for 60 min. By contrast, free CAT retained only 25% 
of activity. A similar result was observed after exposure to 
protease trypsin (6 mg/mL) for 60 min: CAT@COF-42-B 
retained ~100% of its activity, while free CAT retained only 
25% of activity. Next, the influence of heating was evaluated. 
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After treatment under 60 °C for 10 min, free CAT and 
CAT@ZPF-2 retained only 20% and 50% of original activity, 
respectively, while CAT@COF-42-B retained 88% of 
original enzymatic activity. These results revealed that 
CAT@COF-42-B capsules demonstrated superior protective 
effect that surpassed its counterparts such as free CAT and 
CAT@ZPF-2. Furthermore, we investigated the catalytic 
durability and stability of CAT@COF-42-B, which is an 
important criterion for heterogeneous biocatalysts. 
CAT@COF-42-B can be readily recovered without 
significant loss of activity for at least 10 cycles (Figure 4d), 
and negligible leakage was detected during recycling 
experiments (Figure S36b). In comparison, traditional 
porous materials such as SBA-15 and active carbon were 
used to immobilize CAT via the conventional adsorption 
method. Their loading capabilities were demonstrated to be 
0.21 g/g, and 0.09 g/g, respectively (Figure S37 and S38). 
The formed CAT composites exhibited much lower enzyme 
loading or activity compared with the CAT@COF capsule 
(~1.6 g/g, Figure S39), and exhibited no recyclability 
(Figure S40).
Figure 4. Biological activity of CAT@COF capsules. (a) Kinetics 
of degradation of H2O2 for CAT@ZPF-2 (black), CAT@ZPF-
2@COF-42-B (blue) and CAT@COF-42-B (red). (b) Kinetics of 
degradation of H2O2 for CAT@ZPF-2 (black), CAT@ZPF-
2@COF-43-B (blue) and CAT@ COF-43-B (red). (c) Activity 
percentage of CAT, CAT@ZPF-2 and CAT@COF-42-B after 
treatment under various harsh conditions. (d) Recycling 
experiments of CAT@COF-42-B.
Cascade reactions conducted in COF capsule systems. 
In practical applications, two or more enzymes are often 
required to cooperate with each other for advanced 
functions.44 Fabricating multi-enzyme architectures has 
garnered increasing attention with great potential in the 
field of biocatalysis and advanced microdevice, such as 
‘artificial organelles’.27,45,46 For example, GOx can 
spontaneously oxidize glucose into gluconic acid, 
meanwhile producing H2O2 which can serve as the substrate 
of CAT. Combining these two enzymes represents a model 
cascade reaction of a biologically relevant system.47 To 
prove the concept of cascade reactions in COF capsule, GOx 
was firstly encapsulated in COF-42-B capsules like CAT. We 
found that GOx@COF-42-B using ZPF-2 as a sacrificial 
template exhibited an improved activity (~170%) 
compared to GOx@ZPF-2 (Figure 5a). We co-encapsulated 
GOx and CAT into COF-42-B and examined their cascade 
reaction effect. The cascade catalytic efficiency was 
evaluated by the detection of glucose consumption using 
the 3,5-dinitrosalicylic acid (DNS) method (Figure S41).48 
Compared to GOx@ZPF-2, GOx&CAT@ZPF-2 exhibited a 
much higher glucose consumption rate attributed to the 
participation of CAT. As shown in Figure 5b, 
GOx&CAT@COF-42-B composite produced a 130% 
consumption rate of glucose compared to its counterpart 
(GOx&CAT@ZPF-2). These results demonstrated the 
synergistic effect between the two enzymes was 
significantly enhanced after unleashed from ZPF-2 to the 
commodious COF capsule. To further prove the concept of 
cascade reactions in COF capsule, another multi-enzyme 
bioreactor based on GOx&Hemin@COF-42-B was evaluated 
spectroscopically using 3,3',5,5'-Tetramethylbenzidine 
(TMB) and glucose as substrates, accompanying by a 
colorimetric change detectable at 650 nm (Figure 5c). The 
results revealed that GOx&Hemin@COF-42-B showed an 
enhanced activity of 180% compared to its counterpart 
(GOx&Hemin@ZPF-2), and further validated COF capsule 
can provide the freedom to multiple enzymes for better 
cascade performance, which implying potential 
applications in the fabrication of bioreactors or advance 
microdevices.
Figure 5. Catalytic performance of various systems. (a) 
GOx@ZPF-2 and GOx@COF-42-B activity using a colorimetric 
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assay based on the oxidation of ABTS by a Cyt c coupled system 
(λ = 660 nm). (b) GOx&CAT@ZPF-2 and GOx&CAT@COF-42-B 
activity based on the kinetic consumption of glucose. (c) 
GOx&Hemin@ZPF-2 and GOx&Hemin@COF-42-B activity 
using a colorimetric assay.
CONCLUSION
In conclusion, we created a facile three-step approach to 
fabricate novel COF capsules to encapsulate various 
biomacromolecules which cannot be easily incorporated by 
COFs via traditional approaches (i.e. adsorption method). 
Firstly, biomacromolecules are first encapsulated within 
digestible MOFs via in-situ encapsulation to form 
biomacromolecule@MOF systems. This composite can 
further act as templates for the growth of 
biomarcomolecule@MOF@COF core-shell structures. 
Finally, the MOF cores were etched away to unleash the tied 
biomacromolecules within the hollow COF capsule. This 
facile, scalable and effective strategy afforded high-
performance COF bioreactors, which can maintain enzyme 
conformational freedom, stabilize the enzyme and 
meanwhile allow effective diffusion of the substrates and 
products. The COF capsules can provide capacious internal 
environments for the optimal performance of the 
encapsulated biomacromolecules with good protection 
effect against external perturbations. The encapsulated 
enzymes in COF capsules exhibited excellent reusability 
which surpassed the traditional porous materials such as 
SBA-15. In addition, this synthetic platform exhibits high 
versatility and tunability: different sacrificial MOF 
templates (e.g. ZIF-90, ZIF-8 and ZPF-2) and COF shells 
(COF-42-B and COF-43-B), as well as various enzymes (e.g. 
CAT, GOx) were used in this study; various factors such as 
the COF shell thickness and pore size could be fine-tuned to 
optimize the performance the bioreactors. We also 
demonstrated that multiple enzymes could be easily co-
encapsulated within one COF capsule using this synthetic 
strategy and act as advanced bioreactors capable of efficient 
cascade reactions. Such diverse advances may inform the 
further understanding of enzyme behavior in both in vivo 
and in vitro systems, and expand the possibilities for the 
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